StockNews.com Initiates Coverage on Avinger (NASDAQ:AVGR)

StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR) in a research note issued to investors on Thursday morning. The brokerage issued a hold rating on the medical device company’s stock.

Avinger Price Performance

Shares of AVGR stock opened at $0.39 on Thursday. The stock has a market cap of $1.29 million, a PE ratio of -0.04 and a beta of 1.09. The stock has a 50-day moving average of $0.72 and a 200-day moving average of $0.93. Avinger has a one year low of $0.36 and a one year high of $5.45.

Avinger (NASDAQ:AVGR) last issued its quarterly earnings data on Thursday, November 7th. The medical device company reported ($1.82) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.03) by $0.21. The firm had revenue of $1.65 million during the quarter, compared to analysts’ expectations of $1.60 million. Avinger had a negative net margin of 261.06% and a negative return on equity of 5,527.11%. During the same quarter in the previous year, the company earned ($2.92) earnings per share. As a group, research analysts anticipate that Avinger will post -4.69 earnings per share for the current year.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.